Antihistamines in Dermatology
The DOI matches its Crossref record; 96 of the 97 references it cites were found in a registry or an index.
Abstract
Along with antibiotics, antihistamines are the most widely used systemic drugs in dermatology. This is attributable to the major role played by histamine in common diseases such as urticaria and atopic eczema. Of the currently recognised four subtypes of G protein-coupled histamine receptors, only the H 1 and H 2 subtypes have been positively identified in human skin. Traditionally believed to be competitive antagonists of histamine, H 1 and H 2 antihistamines are now considered to behave as inverse agonists. By consensus, H 1 antihistamines are classified as ‘first generation’ (associated with troublesome side-effects including somnolence, anti-adrenergic and atropine-like actions) and ‘second-generation’ compounds (in which these side-effects are reduced or absent). The main indications for H 1 antihistamines in skin are suppression of pruritus in urticaria and atopic eczema, both of which are associated with increased mast cell numbers and tissue histamine levels. However the evidence basis for use in atopic eczema is ambiguous and controversial, even though these drugs are widely used in practice. Currently, significant side-effects are mainly confined to the first-generation compounds and are especially troublesome in the elderly. Psychomotor impairment may persist throughout the day following administration. Anti-cholinergic and anti-α-adrenergic blockade and cardiotoxicity (torsade de pointes) may also occur with first-generation antihistamines. Two early low-sedation second-generation antihistamines caused arrhythmias in a small number of patients but these compounds have now been withdrawn. Generally, the second-generation H 1 antihistamines are well tolerated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Transfer of Drugs and Other Chemicals Into Human Milk
Committee on Drugs (2001) · Pediatrics · doi:10.1542/peds.108.3.776 · Cited by 1,256
On some physiological actions of ergot
Dale, H. H. (1906) · The Journal of Physiology · doi:10.1113/jphysiol.1906.sp001148 · Cited by 1,011
The Blood Vessels of the Human Skin and Their Responses.
(1928) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1928.02690310067037 · Cited by 861
Simons, F. E. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmra033121 · Cited by 697
H1‐antihistamines: inverse agonism, anti‐inflammatory actions and cardiac effects
Leurs, R., Church, M. K., & Taglialatela, M. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.0954-7894.2002.01314.x · Cited by 450 · cited 1×
“In man the H 2 receptor gene encodes for a histamine receptor protein of 359 amino acids with the characteristics of a G protein-coupled receptor and a molecular weight of 40 kDa.Full molecular characterisation of these receptors has brought about major changes in the way the mode of action of H 1 and H 2 antihistamin…”
BackgroundRandomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticaria
Grattan, C. E. H., O’Donnell, B. F., Francis, D. M., Niimi, N., Barlow, R. J., Seed, P. T., Kobza Black, A., & Greaves, M. W. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03664.x · Cited by 413
Self-citationThe Structure Of Normal Skin And The Morphology Of Atopic Eczema
Mihm, M. C., Soter, N. A., Dvorak, H. F., & Austen, K. F. (1976) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12514346 · Cited by 382
Klein, P. A., & Clark, R. A. F. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.12.1522 · Cited by 369 · cited 1×
“yielded contrasting results. A more recent meta-analysis of the effectiveness of H 1 antihistamines in atopic eczema also yielded equivocal results [”
ResultThe safety of asthma and allergy medications during pregnancy
Schatz, M., Zeiger, R. S., Harden, K., Hoffman, C. C., Chilingar, L., & Petitti, D. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70241-0 · Cited by 268
Cardiac Actions of Antihistamines
Woosley, R. L. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001313 · Cited by 256 · cited 1×
“and patients should be cautioned about this. Cardiotoxicity Some first-generation antihistamines can cause cardiac arrhythmias. Diphenhydramine blocks delayed rectifier potassium channels and prolongs the QT interval on the electrocardiogram [”
BackgroundWeiler, J. M., Bloomfield, J. R., Woodworth, G. G., Grant, A. R., Layton, T. A., Brown, T. L., McKenzie, D. R., Baker, T. W., & Watson, G. S. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-5-200003070-00004 · Cited by 251 · cited 1×
“These include tests of psychomotor performance, sensori-motor coordination speed, information processing, sensory skills, and subjective rating scales and include, for example, simulated driving skill tests. It has been shown that licensed doses of first-generation H 1 antihistamines impair motor car driving performan…”
BackgroundSabroe, R. A., Seed, P. T., Francis, D. M., Barr, R. M., Black, A. K., & Greaves, M. W. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70495-0 · Cited by 250 · cited 1×
“Complete remission was reported in 94p receiving steroids compared with 66p on loratidine. Frequently both these agents are prescribed concurrently in acute urticaria and continued until remission occurs. Chronic Urticaria, Including Physical Urticarias, Chronic Idiopathic Urticaria and Autoimmune Urticaria The genera…”
BackgroundSelf-citationExpression cloning of a cDNA encoding the bovine histamine H1 receptor.
Yamashita, M., Fukui, H., Sugama, K., Horio, Y., Ito, S., Mizuguchi, H., & Wada, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11515 · Cited by 233 · cited 1×
“Their functional significance however is unclear. There is little or no evidence of expression of H 3 receptors in skin and their distribution appears to be largely restricted to the central nervous system.The H 1 receptor gene was cloned by Yamashita in 1991 [”
BackgroundP-Glycoprotein Limits the Brain Penetration of Nonsedating but not Sedating H1-Antagonists
Chen, C., Hanson, E., Watson, J. W., & Lee, J. S. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.3.312 · Cited by 227
Assessment of tissue fluid histamine levels in patients with urticaria
Kaplan, A. P., Horáková, Z., & Katz, S. I. (1978) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(78)90113-6 · Cited by 214 · cited 1×
“Elevated tissue levels of histamine have been demonstrated in involved skin of patients with urticaria [”
BackgroundSpencer, C. M., Faulds, D., & Peters, D. H. (1993) · Drugs · doi:10.2165/00003495-199346060-00008 · Cited by 213 · cited 1×
“Cetirizine Cetirizine is the active carboxylated metabolite of the first-generation antihistamine hydroxyzine. Besides being a potent H 1 antihistamine it is also claimed to have significant anti-inflammatory properties, including inhibition of eosinophil chemotaxis [”
BackgroundAcute urticaria: clinical aspects and therapeutic responsiveness.
Zuberbier, T., Iffländer, J., Semmler, C., & Henz, B. (1996) · Acta Dermato-Venereologica · doi:10.2340/0001555576295297 · Cited by 209
The mast cell and mast cell disease
Longley, J., Duffy, T. P., & Kohn, S. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)90336-4 · Cited by 195
Pregnancy Outcome Following First Trimester Exposure to Antihistamines: Meta-Analysis
Seto, A., Einarson, T., & Koren, G. (1997) · American Journal of Perinatology · doi:10.1055/s-2007-994110 · Cited by 193
Diepgen, T. L. (2002) · Pediatric Allergy and Immunology · doi:10.1034/j.1399-3038.2002.01047.x · Cited by 187 · cited 1×
“suggests they may have a role. In this Japanese, randomised multi-centre placebo-controlled double-blind trial of fexofenadine 120 mg/day the verum group showed significant reduction in the primary end-point, pruritus. Large well-designed placebo-controlled studies for both sedative and low-sedation antihistamines are…”
ResultDesloratadine: A new, nonsedating, oral antihistamine
Geha, R. S., & Meltzer, E. O. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.114239 · Cited by 175
Mechanism of action of antipruritic drugs.
Krause, L., & Shuster, S. (1983) · BMJ · doi:10.1136/bmj.287.6400.1199 · Cited by 173 · cited 1×
“Atopic EczemaThe principal symptom of atopic eczema is itching, but its pathophysiology is poorly understood. Several reports have claimed that pruritus in atopic eczema originates in the central nervous system rather than in the skin, based upon the finding that sedative (first-generation) H 1 antihistamines are more…”
BackgroundCardiotoxic effect with convulsions in terfenadine overdose.
Davies, A. J., Harindra, V., McEwan, A., & Ghose, R. R. (1989) · BMJ · doi:10.1136/bmj.298.6669.325 · Cited by 164
The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis
WAHLGREN, C.-F., HAGERMARK, O., & BERGSTROM, R. (1990) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1990.tb14732.x · Cited by 162
Torsade de pointes after astemizole overdose.
Craft, T. M. (1986) · BMJ · doi:10.1136/bmj.292.6521.660 · Cited by 156
Risk of torsades de pointes with non-cardiac drugs
Yap, Y. G. (2000) · BMJ · doi:10.1136/bmj.320.7243.1158 · Cited by 155
Human Skin Mast Cells Express H2 and H4, but not H3 Receptors
Lippert, U., Artuc, M., Grützkau, A., Babina, M., Guhl, S., Haase, I., Blaschke, V., Zachmann, K., Knosalla, M., Middel, P., et al. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22721.x · Cited by 155
Finn, A. F., Kaplan, A. P., Fretwell, R., Qu, R. P., & Long, J. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70091-6 · Cited by 154 · cited 1×
“with little or no sedation or anti-cholinergic activity. Administered in a dosage of 180 mg daily (120 mg daily in the USA) it is effective in the treatment of chronic urticaria, relieving both wheal numbers and size, and pruritus [”
BackgroundMann, R. D. (2000) · BMJ · doi:10.1136/bmj.320.7243.1184 · Cited by 152 · cited 1×
“However not all second generation antihistamines are equally safe in this context. According to Mann et al.’s [”
BackgroundKawashima, M., Tango, T., Noguchi, T., Inagi, M., Nakagawa, H., & Harada, S. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05293.x · Cited by 151 · cited 1×
“and the authors concluded that sedative antihistamines are probably worth prescribing for nocturnal pruritus in atopic eczema. Low-sedation antihistamines seem generally ineffective but a recent large study [”
BackgroundPagliara, A., Testa, B., Carrupt, P., Jolliet, P., Morin, C., Morin, D., Urien, S., Tillement, J. P., & Rihoux, J. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9704311 · Cited by 147
Hindmarch, I., & Shamsi, Z. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.0290s3133.x · Cited by 146 · cited 1×
“Models have been developed to evaluate sedative properties of H 1 antihistamines and their safety consequences [”
MethodMarks, R., & Greaves, M. (1977) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1977.tb00725.x · Cited by 144
Self-citationJohnson, H. H., DeOreo, G. A., Lascheid, W. P., & MITCHELL, F. H. J. B. (1960) · Journal of Investigative Dermatology · doi:10.1038/jid.1960.38 · Cited by 132
Ring, J., Hein, R., Gauger, A., Bronsky, E., Miller, B., & and the Desloratadine Study Group (2001) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2001.00186.x · Cited by 130
BLEEHEN, S. S., Thomas, S. E., Greaves, M. W., Newton, J. L., Kennedy, C., HINDLEY, F., Marks, R., Hazell, M., Rowell, N. R., Fairris, G. M., et al. (1987) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1987.tb04095.x · Cited by 123
Self-citationBenedetti, M. S., Plisnier, M., Kaise, J., Maier, L., Baltes, E., Arendt, C. H., & McCracken, N. W. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100364 · Cited by 116 · cited 1×
“However, the reduction in frequency of attacks did not extend beyond the period of administration of cetirizine and during the 6-month follow-up period. Levocetirizine [ 14m C]levocetirizine, the R enantiomer of cetirizine and its major active metabolite, is the most recently introduced second-generation H 1 antihista…”
BackgroundPeng, Z., Li, H., & Simons, F. E. R. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70357-4 · Cited by 115
Pratt, C. M., Hertz, R. P., Ellis, B. E., Crowell, S. P., Louv, W. C., & Moyé, L. A. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90006-x · Cited by 113 · cited 1×
“.] This drug has been reported to cause ventricular arrhythmias [”
BackgroundYanai, K., Ryu, J. H., Watanabe, T., Iwata, R., Ido, T., Sawai, Y., Ito, K., & Itoh, M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16386.x · Cited by 110
Ciprandi, G., Pronzato, C., Passalacqua, G., Ricca, V., Grogen, J., Mela, G. S., VARESE, P., Bertolini, C., Bagnasco, M., & Canonica, G. W. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)80196-5 · Cited by 107
Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance☆☆☆★★★
Vermeeren, A., & O’Hanlon, J. F. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70240-4 · Cited by 99
Monroe, E. W., Finn, A., Patel, P. M., Guerrero, R., Ratner, P. H., & Bernstein, D. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.143 · Cited by 97
REDIER, H., Chanez, P., Vos, C. D., Rifai, N. E., Clauzel, A. M., Michel, F. B., & Godard, P. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90074-c · Cited by 97 · cited 1×
“They also inhibit eosinophil chemotaxis, adhesion molecule expression and cytokine transcription [”
BackgroundRESPONSES OF HUMAN SKIN BLOOD VESSELS TO SYNTHETIC HISTAMINE ANALOGUES
ROBERTSON, I., & GREAVES, M. W. (1978) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1978.tb01714.x · Cited by 96
Self-citationMeltzer, E. O., Prenner, B. M., & Nayak, A. S. (2001) · Clinical Drug Investigation · doi:10.2165/00044011-200121010-00004 · Cited by 96
Urticaria: Clinical efficacy of cetirizine in comparison with hydroxyzine and placebo
Kalivas, J., Breneman, D., Tharp, M. D., Bruce, S., Bigby, M. E., & nine other investigators (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80246-5 · Cited by 95 · cited 1×
“– although the clinical relevance of this attribute is unclear. Cetirizine is effective in the treatment of chronic urticaria as attested by a number of published studies [”
ResultFailure of terfenadine in relieving the pruritus of atopic dermatitis
Berth‐Jones, J., & GRAHAM-BROWN, R. A. C. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb08196.x · Cited by 95 · cited 1×
“Antihistamines have been used apparently successfully by most dermatologists, allergists, paediatricians and general practitioners for almost 60 years. Therefore it is hard to reject the view that histamine plays a significant role in the itch of atopic eczema and that antihistamines are useful in its management – esp…”
BackgroundResponses of skin blood vessels to bradykinin, histamine and 5‐hydroxytryptamine
Greaves, M. W., & Shuster, S. (1967) · The Journal of Physiology · doi:10.1113/jphysiol.1967.sp008356 · Cited by 93
Self-citationDouble-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis.
Cj, F., Ml, B., Buchman, E., Jt, C., Dockhorn, R. J., Leese, P. T., Miller, J. S., Wasserman, S. I., Jm, Z., & Altman, R. D. (1991) · PubMed · Cited by 91
Prevention of acute urticaria in young children with atopic dermatitis
Simons, F. E. R. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.113866 · Cited by 90 · cited 1×
“In general, patients receiving cetirizine are slightly more liable to complain of sedation than those taking other second-generation antihistamines.A prophylactic role for low-sedation cetirizine has been proposed. In the Early Treatment of the Atopic Child (ETAC study, administration of cetirizine during the first 18…”
BackgroundNeittaanmäki, H., Myöhänen, T., & Fräki, J. E. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)70196-4 · Cited by 88 · cited 1×
“true tachyphylaxis does not occur with H 1 antihistamines even after prolonged treatment. ‘Pseudotachyphylaxis’ (apparent loss of efficacy) is usually due to poor compliance associated with annoying side-effects of mainly first-generation compounds. First-Generation AntihistaminesThese compounds, characterised by intr…”
BackgroundThompson, A. K., Finn, A. F., & Schoenwetter, W. F. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.104680 · Cited by 87 · cited 1×
“It also improves quality of life in patients with chronic urticaria [”
BackgroundINDUCED TOLERANCE IN COLD URTICARIA CAUSED BY COLD-EVOKED HISTAMINE RELEASE
Bentley-Phillips, C. B., Black, A., & Greaves, M. W. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92285-6 · Cited by 86
Self-citationTreatment of itching in atopic eczema with antihistamines with a low sedative profile.
Doherty, V., Sylvester, D. G., Kennedy, C. T., Harvey, S. G., Calthrop, J. G., & Gibson, J. R. (1989) · BMJ · doi:10.1136/bmj.298.6666.96 · Cited by 83
Takahashi, H., Ishida‐Yamamoto, A., & Iizuka, H. (2004) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2004.01618.x · Cited by 81 · cited 1×
“(table 1 ). Second-generation compounds are distinguished from the first generation by comparative freedom from side-effects including sedation and anti-cholinergic actions (dry mouth, blurred vision, constipation).The first generation H 1 antihistamines and, to a lesser extent, loratidine, desloratidine, ebastine and…”
BackgroundOLIVER, F., Amon, E. U., Breathnach, A. S., Francis, D. M., Sarathchandra, P., BLACK, A. K., & Greaves, M. W. (1991) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1991.tb00282.x · Cited by 76
Self-citationTreatment of chronic urticaria with cetirizine dihydrochloride a non-sedating antihistamine
JUHLIN, L., & Arendt, C. (1988) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1988.tb07103.x · Cited by 73
Yoneda, K., Yamamoto, T., Ueta, E., & Osaki, T. (1997) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.73.145 · Cited by 72
Antiallergic Anti-Inflammatory Effects of H1-Antihistamines in Humans
(2002) · Histamine and H1-Antihistamines in Allergic Disease · doi:10.3109/9780203910375-9 · Cited by 70
de la Jolinière, J. B., Sananes, S., Canis, M. J., Levardon, M., Dubuisson, J. B., & Donnez, J. (1992) · PubMed · Cited by 67
Clough, G. F., Boutsiouki, P., & Church, M. K. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.00204.x · Cited by 67 · cited 1×
“proving more potent than loratidine in suppressing the histamine wheal in healthy volunteers [”
BackgroundThe electrocardiographic effects of cetirizine in normal subjects
Sale, M. E., Barbey, J. T., Woosley, R. L., Edwards, D., Yeh, J., Thakker, K. M., & Chung, M. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.140 · Cited by 67
Brostoff, J., Fitzharris, P., Dunmore, C., Theron, M., & Blondin, P. (1996) · Allergy · doi:10.1111/j.1398-9995.1996.tb00092.x · Cited by 65
THE RIDDLE OF THE MAST CELLS A TRIBUTE TO PAUL EHRLICH
Riley, J. (1954) · The Lancet · doi:10.1016/s0140-6736(54)91417-8 · Cited by 61 · cited 1×
“It is stored in the skin mainly in dermal mast cells [”
BackgroundSensory responses of human skin to synthetic histamine analogues and histamine.
Davies, M. G., & Greaves, M. W. (1980) · PubMed · Cited by 60
Self-citationCardiovascular safety of fexofenadine HCl
Pratt, C. M., Brown, A. M., Rampe, D., Mason, J., Russell, T., Reynolds, R. F., & Ahlbrandt, R. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.0290s3212.x · Cited by 56
Effects of H1 antihistamines on adhesion molecules: a possible rationale for long‐term treatment
Ciprandi, G., Passalacqua, G., & Canonica, G. W. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00011.x-i1 · Cited by 53 · cited 1×
“There is also evidence to suggest that the anti-inflammatory actions of H 1 antihistamines (vide supra) may be enhanced by prolonged regular dosage [”
BackgroundImmunology and treatment of mosquito bites
Reunala, T. L., Brummer‐Korvenkontio, H., Lappalainen, P., RÄSÄNEN, L., & Palosuo, T. (1990) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1990.tb02472.x · Cited by 52 · cited 1×
“The role of histamine in the pathophysiology of atopic eczema is controversial, although it probably contributes to the itch in this disorder. Histamine is a mediator of insect bite reactions [”
BackgroundGreaves, M. W. (1970) · Archives of Dermatology · doi:10.1001/archderm.101.4.418 · Cited by 52 · cited 1×
“and release of histamine from skin has been confirmed in acute allergic reactions and in various physical urticarias [”
BackgroundSelf-citationDubertret, L., Aguttes, M. M., & Tonet, J. (1999) · Journal of the European Academy of Dermatology and Venereology · doi:10.1016/s0926-9959(98)00130-5 · Cited by 51
Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils
Nabe, M., Agrawal, D. K., Sarmiento, E. U., & Townley, R. G. (1989) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1989.tb02426.x · Cited by 50 · cited 1×
“In addition antihistamine drugs, now classified as H 1 -inverse agonists, possess anti-inflammatory actions which are independent of their actions on the H 1 receptor. In vitro and animal experiments have shown that besides anti-cholinergic properties, H 1 antihistamines also suppress IgE-mediated histamine release fr…”
BackgroundHistamine: The Quintessential Mediator
Greaves, M. W., & Sabroe, R. A. (1996) · The Journal of Dermatology · doi:10.1111/j.1346-8138.1996.tb02694.x · Cited by 49
Self-citationPaul, E., Berth‐Jones, J., Ortonne, J. ‐., & Stern, M. A. (1998) · Journal of Dermatological Treatment · doi:10.3109/09546639809160545 · Cited by 49
Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis
Friedman, B. S., Santiago, M. L., Berkebile, C., & Metcalfe, D. D. (1993) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(93)90076-r · Cited by 48 · cited 1×
“In this study 817 eczematous infants born of atopic parents were treated with daily cetirizine for 18 months on a double-blind placebo-controlled basis. In a subgroup of infants with more severe eczema there was a statistically significant reduction in the usage of potent topical corticosteroids in the cetirizine-trea…”
BackgroundCentral Anticholinergic Syndrome on Therapeutic Doses of Cyproheptadine
Watemberg, N. M., Roth, K. S., Alehan, F., & Epstein, C. E. (1999) · PEDIATRICS · doi:10.1542/peds.103.1.158 · Cited by 47 · cited 1×
“Adverse Effects of H 1 Antihistamines Anti-Cholinergic and Anti-Adrenergic Actions The selectivity of first-generation antihistamines on the H 1 receptor is not high; these drugs also block cholinergic (muscarinic) and α-adrenergic receptors in licensed dosages. Their safety at licensed dosages has never been formally…”
BackgroundYanai, K., Son, L. Z., Endou, M., Sakurai, E., & Watanabe, T. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00115-5 · Cited by 45
Karppinen, A., Kautiainen, H., Petman, L., Burri, P., & Reunala, T. L. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.13201.x · Cited by 44 · cited 1×
“Oral antihistamines decrease the immediate whealing and pruritus and may reduce itching associated with the subsequent delayed reaction [”
BackgroundSOME ASPECTS OF THE ACTION OF HISTAMINE ANTAGONISTS
Bain, W. A., Hellier, F. F., & Warin, R. (1948) · The Lancet · doi:10.1016/s0140-6736(48)91644-4 · Cited by 41 · cited 1×
“H 1 antihistamines are effective in ameliorating itch, wheal numbers and wheal size in both acute and chronic urticaria. Early experiences were reviewed by Bain, a pharmacologist, and Hellier and Warin [”
BackgroundPichat, P., Angel, I., & Arbilla, S. (1998) · PubMed · Cited by 41
Loratadine in the treatment of mosquito‐bite‐sensitive children
Karppinen, A., Kautiainen, H., Reunala, T. L., Petman, L., Reunala, T. L., & Brummer‐Korvenkontio, H. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00609.x · Cited by 40
Prose, P. H., & Sedlis, E. (1960) · Journal of Investigative Dermatology · doi:10.1038/jid.1960.21 · Cited by 39
Monroe, E. W., Fox, R. W., Green, A. W., IZUNO, C. G. T., Bernstein, D. I., Pleskow, W. W., Willis, I., & Brigante, J. R. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)80230-5 · Cited by 39 · cited 1×
“It is licensed for the indication of urticaria in Europe. Loratidine Loratidine, a long-acting low-sedation antihistamine, has little or no affinity for cholinergic or α-adrenergic receptors and no cardiotoxicity. Patient compliance is good and it is effective in chronic urticaria [”
BackgroundAntihistamines in Urticaria and Angioedema
BLACK, A. K., & Greaves, M. W. (2002) · CRC Press eBooks · doi:10.3109/9780203910375-13 · Cited by 36
Self-citationPRENATAL ANTIHISTAMINE EXPOSURE AND RETROLENTAL FIBROPLASIA
Zierler, S., & Purohit, D. M. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114214 · Cited by 36
Lack of subsensitivity to loratadine during long-term dosing during 12 weeks
Bousquet, J. J., Chanal, I., Skassa-Brociek, W., LEMONIER, C., & Michel, F. B. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80072-7 · Cited by 35
Histamine and leukotriene C4 release in cutaneous mosquito-bite reactions
Horsmanheimo, L., Harvima, I. T., Harvima, R. J., Brummer‐Korvenkontio, H., François, G., & Reunala, T. L. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70165-3 · Cited by 35 · cited 1×
“and may also reduce gastrointestinal colic. Insect Bite Reactions The immediate wheal and flare response to mosquito bite reactions is due to an IgE-mediated reaction involving dermal mast cells and histamine release [”
BackgroundMizolastine: antihistaminic activity from preclinical data to clinical evaluation
Simons, F. E. R. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00002.x · Cited by 32
A low distribution volume as a determinant of efficacy and safety for histamine (H1 antagonists
Tillement, J. P. (1995) · Allergy · doi:10.1111/j.1398-9995.1995.tb04258.x · Cited by 32 · cited 1×
“These actions need to be demonstrated in vivo in human subjects with ordinary therapeutic dosages before their clinical significance can be assessed. Corticosteroids, in licensed dosages both topically and systemically, are an order of magnitude more effective in suppressing inflammation in skin than H 1 antihistamine…”
BackgroundAll antihistamines cross blood-brain barrier
Ramaekers, J. G., & Vermeeren, A. (2000) · BMJ · doi:10.1136/bmj.321.7260.572 · Cited by 27 · cited 1×
“study of prescription event monitoring, the odds ratio for the incidence of sedation was 0.63 for fexofenadine, 2.79 for acrivastine and 3.53 for cetirizine. The comparator in this study, with an odds ratio of 1, was loratidine. These second-generation antihistamines were administered in licensed dosage; at increased…”
BackgroundInfluentialBENADRYL IN THE TREATMENT OF URTICARIA
O’Leary, P., & Farber, E. M. (1945) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(26)04431-9 · Cited by 24
Lack of subsensitivitvy to mizolastine over 8‐week treatment
Bousquet, J. J., Chanal, I., Murrieta, M., & Stalla‐Bourdillon, A. (1996) · Allergy · doi:10.1111/j.1398-9995.1996.tb04601.x · Cited by 23
Loratadine and cetirizine in the treatment of chronic urticaria
Guerra, L., Vincenzi, C., Marchesi, E., Tosti, A., Pretto, E., Bassi, R., Fubbian, P. R., & Costanza, F. D. (1994) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.1994.tb00089.x · Cited by 23
Sedating Effects of AM/PM Antihistamine Dosing with Evening Chlorpheniramine and Morning Terfenadine
Kay, G. G., Plotkin, K. E., Quig, M. B., Starbuck, V. N., & Yasuda, P. S. (1997) · The American Journal of Managed Care · Cited by 22
Analysis of potential adverse drug reactions—A case of mistaken identity
Woosley, R. L., & Darrow, W. R. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90109-0 · Cited by 18
Nutrition and Behavior: The Legend Continues
Accardo, P., & Lindsay, R. L. (1994) · PEDIATRICS · doi:10.1542/peds.93.1.127 · Cited by 7
Cited by
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
“(214,215) Patients with PBC and sicca symptoms may not tolerate the dry-mouth side effect of antihistamines.(215)”
BackgroundMolecular and cellular analysis of human histamine receptor subtypes
Seifert, R., Strasser, A., Schneider, E. H., Neumann, D., Dove, S., & Buschauer, A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.11.001 · Cited by 168
Ohsawa, Y., & Hirasawa, N. (2014) · Allergology International · doi:10.2332/allergolint.13-ra-0675 · Cited by 126
Ohsawa, Y., & Hirasawa, N. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02854.x · Cited by 111
“As plasma histamine levels were reported to be significantly higher in patients with AD than controls (23, 24), this NC/Nga-based model of chronic dermatitis is an important tool for studying the roles of histamine in AD.”
Background
Metadata
- Authors
- Greaves, M. W.
- Affiliations
- National Skin Centre (SG)
- Corresponding author
- Greaves, Malcolm W
- Venue
- Skin Pharmacology and Physiology
- Publisher
- S. Karger AG
- Published
- 2005
- Volume
- 18
- Issue
- 5
- Pages
- 220-229
- ISSN
- 1422-2868 (ISSN-L)
- 1660-5527
- 1660-5535
- OpenAlex
- W2038358638
- Cited by
- 63
- References
- 97
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 7 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 2 · 2014: 5 · 2013: 4 · 2012: 5
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Skin Pharmacology and Physiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Dermatology › Urticaria and Related Conditions
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- antihistamines, histamine H1 receptor antagonists, H2 antihistamines, histamine, histamine receptors, urticaria, atopic dermatitis, pruritus, mast cells, first-generation antihistamines, second-generation antihistamines, adverse effects, drug safety, cardiotoxicity, cardiac arrhythmias, sedation
- MeSH terms
- Dermatology, Histamine, Histamine H1 Antagonists, Humans, Receptors, Histamine, Skin Diseases, Histamine H1 Antagonists, Non-Sedating
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.